| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate |
2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a5e832b0a8b89a12a4f9dd3c2313aa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a42f33436f154e68c706bbdf5abfbdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76b2a07465c26df306b87fd7c2dc7737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cd7f3f4ab97b3a8ea06a5f148231eb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2bdd9806cc00074d1af5991ca02baff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d681e5186f1f5c31341e2d8d1471e048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66f0f3c64027a5dc9c79404b829c03f |
| publicationDate |
2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006306877-A |
| titleOfInvention |
Dosage form, pharmaceutical composition and subtenon delivery method |
| abstract |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for subtenon administration to the posterior part of the eye close to the macula in a mammal having age-related macular degeneration. The composition comprises formulas I, II and III: [Chemical 1] Or a pharmaceutically acceptable salt or solvate thereof. The present invention further provides a method for the treatment of age-related macular degeneration in mammals by administering these dosage forms. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018065920-A |
| priorityDate |
2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |